Veterinary Distribution Market Size is valued at US$ 46,332.0 Mn in 2023 and is predicted to reach US$ 99,338.4 Mn by the year 2034 at an 7.4% CAGR during the forecast period for 2024-2034.
The veterinary distribution industry plays a central role in guaranteeing the availability and accessibility of critical veterinary products, such as pharmaceuticals, vaccines, and diagnostics, to different stakeholders like veterinary hospitals, clinics, and retail pharmacies. Veterinary distribution is defined as the process of getting these critical products from manufacturers to end-users, enabling animal healthcare services in different industries, including companion animals and livestock. It is important for ensuring animal health through access to medicines such as anti-infectives and anti-inflammatory drugs, vaccines to prevent disease, and diagnostics for the detection and monitoring of disease. These are utilized in various settings to prevent, treat, and diagnose diseases in animals.
One of the major driving forces for the veterinary distribution industry is the rising demand for animal protein across the world. With the population of the world increasing and food preferences changing towards more meat and dairy intake, the demand for a healthy and strong livestock industry increases. This calls for effective veterinary distribution channels to provide livestock producers with the necessary medicines and vaccines, facilitating the production of safe and plenty of animal-based food items.
• Elanco
• Merck & Co Inc.
• Boehringer Ingelheim Animal Health
• Alembic Pharmaceuticals Limited
• HIPRA, S.A.
• Norbrook
• Dechra Pharmaceuticals plc
• Mars, Inc.
• Animalcare Group plc
• Vetoquinol S.A.
• Zoetis Services LLC
• Ceva
• Virbac
• Midwest Veterinary Supply
• Petsmart LLC
• Covetrus, Inc
• Pet Supermarket, Inc.
• Petsense
• Petco Animal Supplies, Inc
• Chewy, Inc.
• Tractor Supply Co.
• Shop-Apotheke
• PetFriendly
• Amazon, Inc.
• Walmart
• Gianteagle Pet Pharmacy
• Netmeds
• PetRx
The veterinary distribution market is segmented by products, animal type, distribution channel, sales type. By products, the market is segmented into pharmaceuticals, biologics, medicinal feed additives, pharmaceuticals is sub segmented parasiticides, anti-inflammatory, analgesic, others. Biologics is sub segmented into vaccines and other biologics. Vaccines is sub segmented into modified/ attenuated live, inactivated (killed), other vaccines). By animal type market is segmented into companion animals, production animals. Companion animals is sub segmented into dogs, cats, horses, others. Production animals is sub segmented into cattle, swine, poultry, sheep & goats, and fish. By distribution channel market is segmented into hospital/ clinic pharmacy, retail, e-commerce. By sales type market is segmented into prescription and OTC.
Veterinary biologics, such as vaccines, antibodies, and diagnostic kits, play a critical role in disease prevention, diagnosis, and treatment of animals by taking advantage of immunological effects to improve health and productivity. The segment is fueled by the growing need for preventive healthcare, with vaccines being among the most important factors in the control of infectious diseases in companion animals and livestock. Moreover, the growing world livestock industry requires biologics to ensure animal health and productivity. Advances in technology and innovations in therapeutics and diagnostics continue to drive market expansion by providing better solutions for animal health management.
The expansion of the veterinary distribution industry in the companion animal market is fueled by rising pet ownership and pet humanization, resulting in increased expenditure on their health. Pet owners are spending more on high-level medical care, such as vaccines, diagnostics, and therapeutics, to keep their pets healthy. Improvements in veterinary medicine through technology have also enhanced the standard of treatment and preventive care for companion animals.
The Asia-Pacific veterinary distribution market is expanding at a rapid rate due to several key factors. The expanding livestock industry is driving demand for veterinary healthcare products, including pharmaceuticals and vaccines, to ensure animal health and productivity. Urbanization and increasing disposable incomes, particularly in Japan, South Korea, and Australia, are driving pet ownership, which is boosting demand for companion animal healthcare products and services. Government schemes, such as India's National Livestock Mission, are improving animal health infrastructure and disease control, also supporting market growth. Additionally, technological innovation and digitalization, such as telemedicine, are improving veterinary access in rural and remote regions, increasing the efficiency of veterinary distribution networks.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 46,332.0 Mn |
|
Revenue Forecast In 2034 |
USD 99,338.4 Mn |
|
Growth Rate CAGR |
CAGR of 7.4 % from 2024 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2024 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2024-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Products, Animal Type, Distribution Channel, Sales Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; Southeast Asia |
|
Competitive Landscape |
Elanco, Merck & Co Inc., Boehringer Ingelheim Animal Health, Alembic Pharmaceuticals Limited, HIPRA, S.A., Norbrook, Dechra Pharmaceuticals plc, Mars, Inc., Animalcare Group plc, Vetoquinol S.A., Zoetis Services LLC, Ceva, Virbac, Midwest Veterinary Supply, Petsmart LLC, Covetrus, Inc , Pet Supermarket, Inc., Petsense, Petco Animal Supplies, Inc, Chewy, Inc., Tractor Supply Co., Shop-Apotheke, PetFriendly, Amazon, Inc., Walmart, Gianteagle pet pharmacy, Netmeds , PetRx |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Veterinary Pharma Distribution Market Snapshot
Chapter 4. Global Veterinary Pharma Distribution Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Global Veterinary Pharma Distribution Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Veterinary Pharma Distribution Market Industry Trends
Chapter 5. Veterinary Pharma Distribution Market Segmentation 1: By Products, Estimates & Trend Analysis
5.1. Market Share by Products, 2023 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Products:
5.2.1. Pharmaceuticals
5.2.1.1. Parasiticides
5.2.1.2. Anti-infectives
5.2.1.3. Anti-inflammatory
5.2.1.4. Analgesic
5.2.1.5. Others
5.2.2. Biologics
5.2.2.1. Vaccines
5.2.2.1.1. Modified/ Attenuated Live
5.2.2.1.2. Inactivated (Killed)
5.2.2.1.3. Others
5.2.2.2. Other Biologics
5.2.3. Medicinal Feed Additives
Chapter 6. Veterinary Pharma Distribution Market Segmentation 2: By Animal Type, Estimates & Trend Analysis
6.1. Market Share by Animal Type, 2023 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Animal Type:
6.2.1. Companion Animals
6.2.1.1. Dogs
6.2.1.2. Cats
6.2.1.3. Horses
6.2.1.4. Others
6.2.2. Production Animals
6.2.2.1. Cattle
6.2.2.2. Swine
6.2.2.3. Poultry
6.2.2.4. Sheep & Goats
6.2.2.5. Fish
Chapter 7. Veterinary Pharma Distribution Market Segmentation 3: By Sales Type, Estimates & Trend Analysis
7.1. Market Share by Sales Type, 2023 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Sales Type:
7.2.1. Pharmaceuticals
7.2.1.1. Prescription
7.2.1.2. OTC
7.2.2. Biologics
7.2.2.1. Prescription
7.2.2.2. OTC
7.2.3. Medicinal Feed Additives
7.2.3.1. Prescription
7.2.3.2. OTC
Chapter 8. Veterinary Pharma Distribution Market Segmentation 4: By Distribution Channel, Estimates & Trend Analysis
8.1. Market Share by Distribution Channel, 2023 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Distribution Channel:
8.2.1. Pharmaceuticals
8.2.1.1. Hospital/ Clinic Pharmacy
8.2.1.2. Retail
8.2.1.3. E-commerce
8.2.2. Biologics
8.2.2.1. Hospital/ Clinic Pharmacy
8.2.2.2. Retail
8.2.2.3. E-commerce
8.2.3. Medicinal Feed Additives
8.2.3.1. Hospital/ Clinic Pharmacy
8.2.3.2. Retail
8.2.3.3. E-commerce
Chapter 9. Veterinary Pharma Distribution Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Veterinary Pharma Distribution Market, Regional Snapshot 2023 & 2034
9.2. North America
9.2.1. North America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.2.3. North America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.2.4. North America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Sales Type, 2021-2034
9.2.5. North America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.3. Europe
9.3.1. Europe Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.3.1.1. Germany
9.3.1.2. U.K.
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.3.3. Europe Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.3.4. Europe Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Sales Type, 2021-2034
9.3.5. Europe Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.4.1.1. India
9.4.1.2. China
9.4.1.3. Japan
9.4.1.4. Australia
9.4.1.5. South Korea
9.4.1.6. Hong Kong
9.4.1.7. Southeast Asia
9.4.1.8. Rest of Asia Pacific
9.4.2. Asia Pacific Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.4.3. Asia Pacific Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.4.4. Asia Pacific Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts By Sales Type, 2021-2034
9.4.5. Asia Pacific Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.5. Latin America
9.5.1. Latin America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
9.5.1.1. Brazil
9.5.1.2. Mexico
9.5.1.3. Rest of Latin America
9.5.2. Latin America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.5.3. Latin America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.5.4. Latin America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Sales Type, 2021-2034
9.5.5. Latin America Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.6.1.1. GCC Countries
9.6.1.2. Israel
9.6.1.3. South Africa
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Products, 2021-2034
9.6.3. Middle East & Africa Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Animal Type, 2021-2034
9.6.4. Middle East & Africa Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Sales Type, 2021-2034
9.6.5. Middle East & Africa Veterinary Pharma Distribution Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles (Major Manufacturer)
10.2.1. Elanco
10.2.2. Merck & Co Inc.
10.2.3. Boehringer Ingelheim Animal Health
10.2.4. Alembic Pharmaceuticals Limited
10.2.5. HIPRA, S.A.
10.2.6. Norbrook
10.2.7. Dechra Pharmaceuticals plc
10.2.8. Mars, Inc.
10.2.9. Animalcare Group plc
10.2.10. Vetoquinol S.A.
10.2.11. Zoetis Services LLC
10.2.12. Ceva
10.2.13. Virbac
10.3. Company Profiles (Major Distributors)
10.3.1. Midwest Veterinary Supply
10.3.2. Petsmart LLC
10.3.3. Covetrus, Inc
10.3.4. Pet Supermarket, Inc.
10.3.5. Petsense
10.3.6. Petco Animal Supplies, Inc
10.3.7. Chewy, Inc.
10.3.8. Tractor Supply Co.
10.3.9. Shop-Apotheke
10.3.10. PetFriendly
10.3.11. Amazon, Inc.
10.3.12. Walmart
10.3.13. Gianteagle pet pharmacy
10.3.14. Netmeds
10.3.15. PetRx
Veterinary Distribution Market by Product-
• Pharmaceuticals
o Parasiticides
o Anti-infectives
o Anti-inflammatory
o Analgesic
o Others
• Biologics
o Vaccines
? Modified/ Attenuated Live
? Inactivated (Killed)
? Other Vaccines
o Other Biologics
• Medicinal Feed Additives
Veterinary Distribution Market by Animal Type-
• Companion Animals
o Dogs
o Cats
o Horses
o Others
• Production Animals
o Cattle
o Swine
o Poultry
o Sheep & Goats
o Fish
Veterinary Distribution Market by Distribution Channel-
• Hospital/ Clinic Pharmacy
• Retail
• E-commerce
Veterinary Distribution Market by Sales Type -
• Prescription
• OTC
Veterinary Distribution Market by Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
